Home Other Building Blocks L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine

L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine

CAS No.:
864084-88-8
Catalog Number:
AG003AM4
Molecular Formula:
C29H48N12O8
Molecular Weight:
692.7670
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003AM4
Chemical Name:
L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine
CAS Number:
864084-88-8
Molecular Formula:
C29H48N12O8
Molecular Weight:
692.7670
MDL Number:
MFCD09752700
IUPAC Name:
(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]pentanoic acid
InChI:
InChI=1S/C29H48N12O8/c30-17(10-11-22(31)43)23(44)38-18(8-4-12-36-28(32)33)24(45)40-20(14-16-6-2-1-3-7-16)25(46)41-21(15-42)26(47)39-19(27(48)49)9-5-13-37-29(34)35/h1-3,6-7,17-21,42H,4-5,8-15,30H2,(H2,31,43)(H,38,44)(H,39,47)(H,40,45)(H,41,46)(H,48,49)(H4,32,33,36)(H4,34,35,37)/t17-,18-,19-,20-,21-/m0/s1
InChI Key:
TWWFCOBVAKAKIT-SXYSDOLCSA-N
SMILES:
OC[C@@H](C(=O)N[C@H](C(=O)O)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)N)N)CCCNC(=N)N)Cc1ccccc1
Properties
Complexity:
1170  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
5  
Defined Bond Stereocenter Count:
0
Exact Mass:
692.372g/mol
Formal Charge:
0
Heavy Atom Count:
49  
Hydrogen Bond Acceptor Count:
11  
Hydrogen Bond Donor Count:
12  
Isotope Atom Count:
0
Molecular Weight:
692.779g/mol
Monoisotopic Mass:
692.372g/mol
Rotatable Bond Count:
23  
Topological Polar Surface Area:
372A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-7  
Literature
Title Journal
Opiorphin highly improves the specific binding and affinity of MERF and MEGY to rat brain opioid receptors. Regulatory peptides 20121010
Structure-activity relationship study of opiorphin, a human dual ectopeptidase inhibitor with antinociceptive properties. Journal of medicinal chemistry 20120209
New insights into the pathophysiology of sickle cell disease-associated priapism. The journal of sexual medicine 20120101
Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of opiorphin in human saliva. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111215
Reversal of diabetic vasculopathy in a rat model of type 1 diabetes by opiorphin-related peptides. American journal of physiology. Heart and circulatory physiology 20111001
Inhibition of nociceptive responses after systemic administration of amidated kyotorphin. British journal of pharmacology 20110701
An update on analgesics. British journal of anaesthesia 20110701
On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY. Chemistry & biodiversity 20110501
The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice. Neuroscience letters 20110204
Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice. Behavioural brain research 20101112
Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100801
Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20100601
Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 protein. Journal of inflammation (London, England) 20100101
Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. International journal of impotence research 20100101
The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. American journal of physiology. Cell physiology 20091001
Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice. Peptides 20090701
The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology. The journal of sexual medicine 20090301
Enkephalinase inhibitors: potential agents for the management of pain. Current drug targets 20081001
The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU international 20080901
Markers of erectile dysfunction. Indian journal of urology : IJU : journal of the Urological Society of India 20080101
[Identification of human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways]. Medecine sciences : M/S 20070101
Properties